Logo image of LUNG

PULMONX CORP (LUNG) Stock Earnings & Estimates

NASDAQ:LUNG - US7458481014 - Common Stock

1.69 USD
+0.16 (+10.46%)
Last: 8/22/2025, 8:21:35 PM
1.68 USD
-0.01 (-0.59%)
Pre-Market: 8/25/2025, 4:24:44 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
LUNG revenue by date.LUNG revenue by date.
53.66M
10.82%
68.675M
27.98%
83.789M
22.01%
92.423M
10.30%
106.03M
14.72%
129.37M
22.01%
182.33M
40.94%
327.65M
79.70%
438.08M
33.70%
760.44M
73.58%
882.23M
16.02%
EBITDA
YoY % growth
LUNG ebitda by date.LUNG ebitda by date.
-57.13M
-23.05%
-60.387M
-5.70%
-54.511M
9.73%
-38.828M
28.77%
-33.779M
13.00%
-20.018M
40.74%
-37.434M
-87.00%
N/AN/AN/AN/A
EBIT
YoY % growth
LUNG ebit by date.LUNG ebit by date.
-58.64M
-23.97%
-61.935M
-5.62%
-56.004M
9.58%
-63.625M
-13.61%
-56.857M
10.64%
-38.366M
32.52%
309.397K
100.81%
102.29M
32,961.13%
181.74M
77.67%
449.43M
147.29%
538.22M
19.76%
Operating Margin
LUNG operating margin by date.LUNG operating margin by date.
-109.28%-90.19%-66.84%-68.84%-53.62%-29.66%0.17%31.22%41.49%59.10%61.01%
EPS
YoY % growth
LUNG eps by date.LUNG eps by date.
-1.59
-21.37%
-1.60
-0.63%
-1.40
12.50%
-1.57
-12.35%
-1.40
10.77%
-1.07
24.06%
-0.03
97.13%
2.14
7,083.33%
3.64
70.41%
8.64
137.25%
9.73
12.63%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.43
-19.00%
-0.39
-19.31%
-0.35
2.96%
-0.33
14.11%
-0.35
18.45%
-0.33
16.45%
-0.22
35.77%
-0.22
31.25%
-0.28
21.17%
-0.23
28.68%
Revenue
Q2Q % growth
21.201M
3.99%
23.895M
0.55%
25.214M
11.87%
26.744M
12.09%
23.817M
12.34%
27.455M
14.90%
26.765M
6.15%
28.56M
6.79%
27.224M
14.30%
30.58M
11.38%
EBITDA
Q2Q % growth
-11.221M
13.22%
-10.193M
14.51%
-7.582M
46.92%
-7.067M
50.33%
-9.147M
18.48%
-8.015M
21.37%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-17.372M
-22.96%
-16.293M
-21.44%
-14.15M
2.84%
-13.911M
6.03%
-15.858M
8.72%
-14.56M
10.64%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.38
-8.57%
-0.410.036.86%
Q1 2025
Q2Q % growth
-0.36 -0.410.0511.73%
Q4 2024
Q2Q % growth
-0.33
8.33%
-0.460.1327.70%
Q3 2024
Q2Q % growth
-0.36
7.69%
-0.460.1021.31%
Q2 2024
Q2Q % growth
-0.35
18.60%
-0.430.0819.29%
Q1 2024
Q2Q % growth
-0.36
14.29%
-0.470.1123.51%
Q4 2023
Q2Q % growth
-0.36
5.26%
-0.420.0613.32%
Q3 2023
Q2Q % growth
-0.39
-2.63%
-0.440.0510.63%
Q2 2023
Q2Q % growth
-0.43
-7.50%
-0.450.023.49%
Q1 2023
Q2Q % growth
-0.42
2.33%
-0.450.036.42%
Q4 2022
Q2Q % growth
-0.38
-8.57%
-0.420.0410.51%
Q3 2022
Q2Q % growth
-0.38
-35.71%
-0.400.026.06%
Q2 2022
Q2Q % growth
-0.40
-17.65%
-0.420.024.32%
Q1 2022
Q2Q % growth
-0.43
-26.47%
-0.38-0.05-13.59%
Q4 2021
Q2Q % growth
-0.35
-29.63%
-0.370.024.77%
Q3 2021
Q2Q % growth
-0.28
87.61%
-0.380.1026.23%
Q2 2021
Q2Q % growth
-0.34 -0.380.0410.36%
Q1 2021
Q2Q % growth
-0.34 -0.390.0511.88%
Q4 2020
Q2Q % growth
-0.27 -0.280.014.78%
Q3 2020
Q2Q % growth
-2.26 -4.412.1548.71%
LUNG Yearly EPS VS EstimatesLUNG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4 6 8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
23.859M
14.80%
23.938M-79K-0.33%
Q1 2025
Q2Q % growth
22.538M
19.54%
22.474M64K0.28%
Q4 2024
Q2Q % growth
23.765M
23.28%
22.736M1.029M4.53%
Q3 2024
Q2Q % growth
20.387M
15.39%
20.694M-307K-1.48%
Q2 2024
Q2Q % growth
20.783M
20.87%
20.536M247K1.20%
Q1 2024
Q2Q % growth
18.854M
29.71%
18.251M603K3.30%
Q4 2023
Q2Q % growth
19.278M
24.94%
18.639M639K3.43%
Q3 2023
Q2Q % growth
17.668M
30.87%
16.714M954K5.71%
Q2 2023
Q2Q % growth
17.194M
23.25%
16.178M1.016M6.28%
Q1 2023
Q2Q % growth
14.535M
34.71%
13.764M771K5.60%
Q4 2022
Q2Q % growth
15.43M
12.55%
14.263M1.167M8.18%
Q3 2022
Q2Q % growth
13.5M
1.81%
15.215M-1.715M-11.27%
Q2 2022
Q2Q % growth
13.95M
14.34%
14.003M-53K-0.38%
Q1 2022
Q2Q % growth
10.79M
16.77%
9.446M1.344M14.23%
Q4 2021
Q2Q % growth
13.71M
39.47%
14.527M-817K-5.62%
Q3 2021
Q2Q % growth
13.26M
24.98%
13.441M-181K-1.35%
Q2 2021
Q2Q % growth
12.2M
232.43%
10.718M1.482M13.83%
Q1 2021
Q2Q % growth
9.24M
7.19%
8.3M940K11.33%
Q4 2020
Q2Q % growth
9.83M
-5.02%
8.984M846K9.42%
Q3 2020
Q2Q % growth
10.61M
16.59%
8.534M2.076M24.33%
Q2 2020
Q2Q % growth
3.67M
-50.20%
%
Q1 2020
Q2Q % growth
8.62M
49.13%
%
LUNG Yearly Revenue VS EstimatesLUNG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-6.06% -10.67% -0.7% -0.7%
Revenue-12.43% -12.68% -6.54% -6.54%